pI: 7.8607 |
Length (AA): 519 |
MW (Da): 59916 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 5 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
235 | 454 | 2i7n (A) | 373 | 591 | 21.00 | 0 | 1 | 0.593992 | 0.28 |
247 | 455 | 3mk6 (A) | 159 | 367 | 24.00 | 0 | 1 | 0.637797 | 0.03 |
273 | 368 | 2ews (A) | 92 | 204 | 32.00 | 0.00027 | 0.4 | 0.279771 | 1.13 |
237 | 442 | 3mk6 (A) | 137 | 341 | 29.00 | 0 | 1 | 0.66153 | -0.01 |
278 | 373 | 2ews (A) | 92 | 204 | 32.00 | 0.00027 | 0.4 | 0.277606 | 1.13 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | intra-erythrocytic - 32 hs. | Otto TD |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | intra-erythrocytic - 16 hs, intra-erythrocytic - 24 hs, intra-erythrocytic - 48 hs, early trophozoite, late trophozoite, Sporozoite. | Otto TD PlasmoDB Zanghi G |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | intra-erythrocytic - 0 hs, intra-erythrocytic - 8 hs, intra-erythrocytic - 40 hs, sporozoite, early schizont, late ring, Oocyst, Ring. | Otto TD PlasmoDB Zanghi G |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Lower 20-40% percentile | late schizont, Male Gametocyte. | PlasmoDB Lasonder E |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Lower 0-20% percentile | Female Gametocyte. | Lasonder E |
PlasmoDB | Data on upregulation of P. falciparum genes in different life cycle stages, combined from several microarray experiments available in PlasmoDB |
Lasonder E | Integrated transcriptomic and proteomic analyses of P. falciparum gametocytes. Molecular insight into sex-specific processes and translational repression. |
Otto TD | New insights into the blood-stage transcriptome of Plasmodium falciparum using RNA-Seq. |
Zanghi G | A Specific PfEMP1 Is Expressed in P. falciparum Sporozoites and Plays a Role in Hepatocyte Infection. |
Ortholog group members (OG5_126914)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT1G60440 | Pantothenate kinase 1 |
Arabidopsis thaliana | AT4G32180 | pantothenate kinase 2 |
Babesia bovis | BBOV_II001350 | hypothetical protein |
Brugia malayi | Bm1_40300 | pantothenate kinase family protein |
Candida albicans | CaO19.13022 | putative pantothenate kinase. |
Candida albicans | CaO19.5576 | putative pantothenate kinase. |
Candida albicans | CaO19.5577 | putative pantothenate kinase. |
Candida albicans | CaO19.13023 | putative pantothenate kinase. |
Caenorhabditis elegans | CELE_C42D8.3 | Protein PNK-4 |
Caenorhabditis elegans | CELE_C10G11.5 | Protein PNK-1, isoform B |
Cryptosporidium hominis | Chro.70552 | hypothetical protein |
Cryptosporidium parvum | cgd7_4950 | pantothenate kinase 4, rnaseH fold |
Dictyostelium discoideum | DDB_G0290401 | pantothenate kinase |
Drosophila melanogaster | Dmel_CG5828 | CG5828 gene product from transcript CG5828-RB |
Drosophila melanogaster | Dmel_CG5725 | fumble |
Echinococcus granulosus | EgrG_000497400 | pantothenate kinase 4 |
Entamoeba histolytica | EHI_183060 | pantothenate kinase 1, putative |
Echinococcus multilocularis | EmuJ_000497400 | pantothenate kinase 4 |
Giardia lamblia | GL50803_5857 | Pantothenate kinase 4 |
Homo sapiens | ENSG00000157881 | pantothenate kinase 4 |
Homo sapiens | ENSG00000152782 | pantothenate kinase 1 |
Homo sapiens | 79646 | pantothenate kinase 3 |
Homo sapiens | ENSG00000125779 | pantothenate kinase 2 |
Leishmania braziliensis | LbrM.28.0150 | pantothenate kinase subunit, putative |
Leishmania donovani | LdBPK_280140.1 | pantothenate kinase subunit, putative |
Leishmania infantum | LinJ.28.0140 | pantothenate kinase subunit, putative |
Leishmania major | LmjF.28.0140 | pantothenate kinase subunit, putative |
Leishmania mexicana | LmxM.28.0140 | pantothenate kinase subunit, putative |
Loa Loa (eye worm) | LOAG_06143 | pantothenate kinase |
Mus musculus | ENSMUSG00000018846 | pantothenate kinase 3 |
Mus musculus | ENSMUSG00000029056 | pantothenate kinase 4 |
Mus musculus | ENSMUSG00000033610 | pantothenate kinase 1 |
Mus musculus | ENSMUSG00000037514 | pantothenate kinase 2 |
Neospora caninum | NCLIV_060530 | hypothetical protein |
Oryza sativa | 4340439 | Os06g0207000 |
Oryza sativa | 4347680 | Os09g0533100 |
Onchocerca volvulus | OVOC5238 | Fumble homolog |
Plasmodium berghei | PBANKA_1022600 | pantothenate kinase 1, putative |
Plasmodium falciparum | PF3D7_1420600 | pantothenate kinase 1, putative |
Plasmodium knowlesi | PKNH_1337400 | pantothenate kinase 1, putative |
Plasmodium vivax | PVX_085450 | pantothenate kinase, putative |
Plasmodium yoelii | PY06793 | hypothetical protein |
Saccharomyces cerevisiae | YDR531W | pantothenate kinase |
Schistosoma japonicum | Sjp_0120430 | hypothetical protein |
Schistosoma japonicum | Sjp_0079760 | ko:K09680 type II pantothenate kinase, putative |
Schistosoma mansoni | Smp_064750.2 | pantothenate kinase |
Schistosoma mansoni | Smp_064750.1 | pantothenate kinase |
Schmidtea mediterranea | mk4.009378.05 | |
Schmidtea mediterranea | mk4.010923.00 | Pantothenate kinase 4 |
Schmidtea mediterranea | mk4.002538.01 | |
Schmidtea mediterranea | mk4.003254.01 | |
Schmidtea mediterranea | mk4.005749.01 | Pantothenate kinase 4 |
Schmidtea mediterranea | mk4.003254.02 | Pantothenate kinase 4 |
Schmidtea mediterranea | mk4.009378.02 | |
Trypanosoma brucei gambiense | Tbg972.11.8330 | pantothenate kinase subunit, putative |
Trypanosoma brucei | Tb927.11.7290 | pantothenate kinase subunit, putative |
Trypanosoma congolense | TcIL3000_0_00870 | pantothenate kinase subunit, putative |
Trypanosoma cruzi | TcCLB.506779.80 | pantothenate kinase subunit, putative |
Trypanosoma cruzi | TcCLB.511153.120 | pantothenate kinase subunit, putative |
Toxoplasma gondii | TGME49_307770 | fumble protein |
Theileria parva | TP04_0450 | hypothetical protein |
Trichomonas vaginalis | TVAG_601540 | pantothenate kinase, putative |
Trichomonas vaginalis | TVAG_328400 | pantothenate kinase, putative |
Trichomonas vaginalis | TVAG_562330 | pantothenate kinase, putative |
Trichomonas vaginalis | TVAG_569390 | pantothenate kinase, putative |
Trichomonas vaginalis | TVAG_142730 | conserved hypothetical protein |
Trichomonas vaginalis | TVAG_364740 | pantothenate kinase, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb11.02.5190 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb11.02.5190 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (6 days) | alsford |
Tb11.02.5190 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb11.02.5190 | Trypanosoma brucei | significant gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_C10G11.5 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_C10G11.5 | Caenorhabditis elegans | larval arrest | wormbase |
CELE_C10G11.5 | Caenorhabditis elegans | slow growth | wormbase |
CELE_C10G11.5 | Caenorhabditis elegans | sterile | wormbase |
CELE_C42D8.3 | Caenorhabditis elegans | slow growth | wormbase |
YDR531W | Saccharomyces cerevisiae | inviable | yeastgenome |
PBANKA_1022600 | Plasmodium berghei | Dispensable | plasmo |
TGME49_307770 | Toxoplasma gondii | Probably essential | sidik |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
Affected Entity | Phenotypic quality | Occurs in | Occurs at | Evidence | Observed in | Drugs/Inhibitors |
---|---|---|---|---|---|---|
growth (GO:0040007) | lethal (sensu genetics) (PATO:0000718) | multi-cellular organism (CARO:0000012) | bloodstream stage (PLO:0040) | in vivo inhibition (TDR:00016) | Plasmodium falciparum | 1852 563417 |
Annotator: | saralph@unimelb.edu.au. | Comment: | Drug: Pantothenic Acid analogues. . | References: | 15673744 16251308 9553068 | |
growth (GO:0040007) | lethal (sensu genetics) (PATO:0000718) | multi-cellular organism (CARO:0000012) | bloodstream stage (PLO:0040) | in vivo inhibition (TDR:00016) | Plasmodium vinckei | 1852 563417 |
Annotator: | saralph@unimelb.edu.au. | Comment: | Drug: Pantothenic Acid analogues. . | References: | 15673744 16251308 9553068 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Compound | Source | Reference |
---|---|---|
Curated by TDRTargets | References | |
Curated by TDRTargets | References |
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Homo sapiens | pantothenate kinase 2 | Compounds | References |
Homo sapiens | pantothenate kinase 3 | Compounds | References |
Homo sapiens | pantothenate kinase 1 | Compounds | References |
4 literature references were collected for this gene.